Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Precision Biosciences (DTIL) Interest Expenses (2019 - 2025)

Precision Biosciences (DTIL) has disclosed Interest Expenses for 6 consecutive years, with $362000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Interest Expenses rose 41.41% to $362000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $1.5 million, a 25.55% decrease, with the full-year FY2024 number at $1.8 million, down 20.09% from a year prior.
  • Interest Expenses was $362000.0 for Q3 2025 at Precision Biosciences, up from $358000.0 in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $579000.0 in Q4 2023 to a low of $24000.0 in Q2 2021.
  • A 5-year average of $351611.1 and a median of $377000.0 in 2024 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: surged 1142.86% in 2023, then plummeted 55.56% in 2024.
  • Precision Biosciences' Interest Expenses stood at $53000.0 in 2021, then surged by 816.98% to $486000.0 in 2022, then grew by 19.14% to $579000.0 in 2023, then crashed by 32.3% to $392000.0 in 2024, then dropped by 7.65% to $362000.0 in 2025.
  • Per Business Quant, the three most recent readings for DTIL's Interest Expenses are $362000.0 (Q3 2025), $358000.0 (Q2 2025), and $354000.0 (Q1 2025).